- Enviar a un amigo
- RSS
- google +
- Versión impresa
- Enviar esta página por correo electrónico
Noticias (Seguridad de los Consumidores)
Las noticias y eventos de Salud-UE se generan automáticamente según criterios fijados por la Comisión Europea. Puede haber errores de clasificación.
EU drugs and maritime agencies open their doors to the public on inauguration of Praça Europa» europa.eu
The EU drugs agency (EMCDDA) and the European Maritime Safety Agency (EMSA) will open their doors to the public this Thursday 20 June on the occasion of the inauguration of Praça Europa, the square o[...]New publication: Scientific Committees - 2012 Opinions CD now available» europa.eu
European Commission - When preparing its policy and proposals relating to consumer safety, public health and the environment, the Commission relies on independent Scientific Committees to provide it [...]Message by Tonio Borg on the occasion of the 54th GIRP's Annual General Meeting - 17 June 2013»
Message by Tonio Borg on the occasion of the 54th GIRP's Annual General Meeting - 17 June 2013
Scientific Committee on Consumer Safety SCCS: Perfume Allergies»
A layman version is now available for the 'Opinion on Fragrance allergens in cosmetic products'
Registration opens for workshop on EMA-HTA parallel scientific advice in drug development» europa.eu
The European Medicines Agency (EMA) is inviting expressions of interest in attending its workshop on parallel scientific advice in drug development with health-technology-assessment (HTA) bodies on 2[...]Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 10-13 June 2013» europa.eu
The Pharmacovigilance Risk Assessment Committee (PRAC) made recommendations on four safety referrals at its June 2013 meeting.[...]Food: Questions and Answers on new rules for specific groups of consumers» europa.eu
European Commission MEMO Brussels, 11 June 2013 What does this Regulation change? The Regulation amends the legislation that applies to foods for particular nutritional uses ('dietetic foods'). For e[...]Health and safety at work: Commission opens public consultation on future EU policy framework» europa.eu
Public consultations[...]US - Coming soon? Nutritional labels on alcohol (1.6.13)» eurocare.org
Alcohol beverages soon could have nutritional labels like those on food packaging, but only if the producers want to put them there. Read more[...]Examining food labelling across Europe» europa.eu
The FLABEL project ('Food Labelling to Advance to Better Education for Life') was the first EU-funded research programme to examine nutrition labelling when it was launched three years ago. Now havin[...]Scientific guideline: Draft guideline on similar biological medicinal products containing biotechnology-derived proteins as active substance: non-clinical and clinical issues, draft: consultation open» europa.eu
This guideline lays down the non-clinical and clinical requirements for a biological medicinal product claiming to be similar to another one already marketed ([...]US - Coming soon? Nutritional labels on alcohol (1.6.13)» eurocare.org
Alcohol beverages soon could have nutritional labels like those on food packaging, but only if the producers want to put them there. Full article[...]Regulatory and procedural guideline: Draft guideline on the acceptability of names for human medicinal products processed through the centralised procedure, draft: consultation open» europa.eu
The current update of this guideline provides further recommendations on the requirements for acceptability and submission of proposed (invented) names of medicinal products processed through the cen[...]Scientific guideline: Guideline on good pharmacovigilance practices (GVP): Module VI – Management and reporting of adverse reactions to medicinal products, draft: consultation open» europa.eu
This Module addresses the legal requirements detailed in Title IX of Directive 2001/83/EC [DIR] and Chapter 3 of Regulation (EC) No 726/2004 [REG], which are applicable to competent authorities in Me[...]Scientific guideline: Guideline on good pharmacovigilance practices (GVP): Module XVI– Risk minimisation measures: selection of tools and effectiveness indicators, draft: consultation open» europa.eu
Risk minimisation measures are public health interventions intended to prevent or reduce the occurrence of adverse reactions associated with the exposure to a medicine, or to reduce their severity or[...]Evidence confirms that urgent improvements are needed in alcohol labelling» eurocare.org
This month the European Journal of Public Health Advance Access published an article by renowned researchers confirming the need for better labelling of alcoholic beverages.[...]Public consultation open on guideline on the acceptability of names for human medicines» europa.eu
The European Medicines Agency has released the sixth revision of the guideline on the acceptability of names for human medicinal products processed through the centralised procedure for public consul[...]Scientific guideline: Concept paper on the need for revision of the guideline on clinical investigation of medicinal products for the treatment of venous thromboembolic disease, draft: consultation open» europa.eu
Since the publication of the EMA Guidance on clinical investigation of medicinal products for the treatment of venous thromboembolic disease (CPMP/EWP/563/98) in 2000, there has been an intense resea[...]World No Tobacco Day - message from Health and Consumer Policy Commissioner, Tonio Borg» europa.eu
[...]Scientific guideline: Draft guideline on the clinical development of medicinal products intended for the treatment of pain, draft: consultation open» europa.eu
This document is intended to give guidance on the investigation of medicinal products to be used in the treatment of nociceptive pain and / or of central and peripheral neuropathic pain.[...]ECDC updates Rapid Risk Assessment on Middle East respiratory syndrome coronavirus (novel coronavirus)» europa.eu
ECDC has published an update of its rapid risk assessment on Middle East respiratory syndrome coronavirus (MERS-CoV), previously referred to as the novel coronavirus. 17/05/2013 00:00[...]Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 13-16 May 2013» europa.eu
European Medicines Agency's Pharmacovigilance Risk Assessment Committee (PRAC) has concluded that the benefits of Diane 35 (cyproterone acetate 2 mg, ethinylestradiol 35 micrograms) and its generics [...]Food Allergen Labelling (eufic.org, ) »
Effective labelling is essential to enable allergic consumers manage their condition. Specific rules regarding the labelling of allergenic ingredients in pre-packed foods are established in European [...]Mr Neven Mimica named as Commissioner-designate for consumer protection» europa.eu
European Commission Press release Brussels, 24 April 2013 Mr Neven Mimica has today been named by Croatia as Commissioner-designate. President Barroso has met with Mr Mimica and has confirmed his agr[...]Joint Statement by Commissioners Andris Piebalgs (Development), Máire Geoghegan-Quinn (Research and Innovation) and Tonio Borg (Health and Consumer) on the eve of the World Malaria Day» europa.eu
European Commission MEMO Brussels, 24 April 2013 Millions of people living in highly endemic areas continue to lack access to effective malaria prevention, diagnostic testing, and treatment. As a res[...]The European Soundscape Award 2013 - open for applications» europa.eu
Do you want to make some noise about your campaign for a quiet environment? Or do you want to show others how your community solved a noise problem and created a healthier soundscape? The European So[...]Research Headlines - Nanotechnology to fight hospital superbugs» europa.eu
Each year, twice as many people die in Europe from hospital acquired infections than from road accidents. These infectious diseases have developed antibiotic resistance and spread despite the best ef[...]First meeting of the newly appointed Scientific Committees, Luxembourg, 11-12 April 2013 – Presentations now available» europa.eu
European Commission - When preparing its policy and proposals relating to consumer safety, public health and the environment, the Commission relies on independent Scientific Committees to provide it [...]Inadequate data prevent EFSA from concluding on safety of GM maize 98140» europa.eu
Published on: 16 April 2013 The European Food Safety Authority (EFSA) could not conclude on the safety of genetically modified (GM) maize 98140 after the applicant failed to supply essential data to [...]ECDC Risk Assessment on avian influenza A(H7N9) virus in China» europa.eu
The updated ECDC risk assessment of 12 April concludes that the risk of avian influenza A(H7N9) virus spreading to Europe via humans or through poultry is low at this time. 12/04/2013 00:00[...]EFSA seeks new experts to join two Scientific Panels» europa.eu
EFSA is the EU risk assessment body for food and feed safety. It provides independent scientific advice to risk managers.[...]EU agencies consider phenylbutazone detected in horsemeat of low concern for consumers; recommend improved horse traceability and monitoring of veterinary medicinal residues» europa.eu
A joint assessment from the European Food Safety Authority (EFSA) and the European Medicines Agency (EMA) concludes that the illegal presence of residues of phenylbutazone in horsemeat is of low conc[...]Guideline on good pharmacovigilance practices: P I - Vaccines for prophylaxis against infectious diseases – Definitions for inclusion in GVP annex I: consultation open» europa.eu
Guideline on good pharmacovigilance practices (GVP): P I - Vaccines for prophylaxis against infectious diseases – Definitions for inclusion in GVP annex I Guideline on good pharmacovigilance practice[...]Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 8-11 April 2013» europa.eu
The European Medicines Agency's Pharmacovigilance Risk Assessment Committee (PRAC) has recommended restrictions in the use of Protelos/Osseor (strontium ranelate) based on the outcome of a routine be[...]Guideline on good pharmacovigilance practices: Product-or population-specific considerations I: Vaccines for prophylaxis against infectious diseases: consultation open» europa.eu
The objective of this module is to strengthen the conduct of pharmacovigilance for vaccines. It should be noted that the overall objectives and processes of pharmacovigilance are no different for vac[...]First meeting of the newly appointed Scientific Committees»
Today, the newly appointed scientists who are to provide the Commission with independent advice on scientifically complex and politically sensitive issues relating to consumer safety, public health and the environment, meet for the first time in Luxembourg.
